SECTOR : Biotech
ENTRY DATE : 2018
BUSINESS : Venture Capital
WEB : antabio.com
ANTABIO
Fighting drug resistant infections
Antabio is a Toulouse-based private biotech company developing novel antibacterials targeting drug-resistant pathogens that are deemed a critical priority by the WHO.
PRESS RELEASE :
12/07/2018 • ANTABIO Completes €12.5m Series A
Read